Jacalyn McCloskey
Obstetrics & Gynecology · Birmingham, MINPI 1629069646
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 59 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 18.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $496 and has fallen 71.1% since, to $143 in 2025.
Across 59 payments — averaging $20.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$222
- Mayne Pharma Commercial LLC$99
- Organon$95
- AbbVie$95
- Astellas Pharma US Inc$88
- Daiichi Sankyo Inc.$85
- plus $550 from 22 others
What the payments were for
- Food & beverage$1,234100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 5 | $222 |
| Mayne Pharma Commercial LLC | 5 | $99 |
| Organon | 4 | $95 |
| AbbVie | 5 | $95 |
| Astellas Pharma US Inc | 6 | $88 |
| Daiichi Sankyo Inc. | 5 | $85 |
| Hologic Sales And Service, LLC | 3 | $80 |
| Sage Therapeutics, LLC | 2 | $58 |
| Molnlycke Health Care US, LLC | 2 | $37 |
| Channel Medsystems, Inc. | 1 | $36 |
| Pfizer | 2 | $35 |
| Covidien LP | 2 | $35 |
| Dysis Medical, Inc. | 2 | $31 |
| Sumitomo Pharma America, Inc. | 1 | $26 |
| Johnson & Johnson | 1 | $23 |
| Merck | 1 | $22 |
| Agile Therapeutics, Inc. | 1 | $21 |
| Bayer | 1 | $20 |
| Coopersurgical, Inc. | 1 | $19 |
| Exeltis, USA Inc. | 1 | $16 |
| Gynesonics, Inc. | 1 | $15 |
| Myriad Women's Health, Inc. | 1 | $13 |
| Mylan Pharmaceuticals Inc. | 1 | $12 |
| Shield Therapeutics Inc | 1 | $12 |
| Minerva Surgical, Inc | 1 | $12 |
| Therapeuticsmd, Inc. | 1 | $12 |
| Meditrina | 1 | $11 |
| Alydia Health | 1 | $4 |
How this compares
$1,234 in reported general payments places this provider in the 70th percentile of 1,474 obstetrics & gynecology providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 12 | $1,912 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Birmingham
- David EisensteinDetroit$272K
- Peter TsengPort Huron$178K
- Robert ValiceChesterfield$175K
- Brent DavidsonDetroit$171K
- Michael EngelLake Orion$165K
- Ethan GoldsteinBloomfield Hills$140K
- Jay FisherWest Bloomfield$136K
- Barbara DepreeZeeland$118K
- Rabbie HannaDetroit$105K
- Gregory GresselGrand Rapids$85K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.